These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16380801)

  • 1. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):2011; author reply 2011. PubMed ID: 16380801
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Sharquie KE; Abdulla MS
    Saudi Med J; 2005 Jun; 26(6):1013-5. PubMed ID: 15983698
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo?
    Majid I
    Indian J Dermatol Venereol Leprol; 2010; 76(3):254-8. PubMed ID: 20445295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial.
    Satyanarayan HS; Kanwar AJ; Parsad D; Vinay K
    Indian J Dermatol Venereol Leprol; 2013; 79(4):525-7. PubMed ID: 23760325
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
    Klahan S; Asawanonda P
    Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.
    Joshipura D; Alomran A; Zancanaro P; Rosmarin D
    J Am Acad Dermatol; 2018 Jun; 78(6):1205-1207.e1. PubMed ID: 29438765
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.
    Mehrabi D; Pandya AG
    Arch Dermatol; 2006 Jul; 142(7):927-9. PubMed ID: 16847214
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.